Rejection

(redirected from Antibody-Mediated Rejection)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Encyclopedia.

Rejection

Refusal by a bank to grant credit, usually because of the applicants financial history, or refusal to accept a security presented to complete a trade, usually because of a lack of proper endorsements or violation of rules of a firm.

Rejection

1. A bank's refusal to grant a line of credit. This often applies to the refusal to grant a mortgage loan to an uncreditworthy person or a business loan to someone without a proper business plan.

2. An investor's refusal to accept a security presented to him/her/it. Reasons for this include suspicion of fraud or improperly filled-out forms.

3. Refusal to provide insurance coverage because the insurance company believes that the claim describes a service or situation that the policy does not cover.

rejection

The refusal to accept a security that has been delivered by a customer or broker. A questionable certificate or an improper endorsement are reasons for rejection.
References in periodicals archive ?
Nakada et al., "Probable C4dnegative accelerated acute antibody-mediated rejection due to non-HLA antibodies," Nephrology, vol.
There is no evidence of acute antibody-mediated rejection according to the 2015 Banff classification (g0, ptc0, and no C4d deposit by immunofluorescence (not shown)).
Dhanireddy, "Antibody-mediated rejection: What is the clinical relevance?" Current Opinion in Organ Transplantation, vol.
Arias Rodriguez, "Relationship between albuminuria during the first year and antibody-mediated rejection in protocol biopsies in kidney transplant recipients," Transplantation Proceedings, vol.
Chadban, "The treatment of acute antibody-mediated rejection in kidney transplant recipients--a systematic review," Transplantation, vol.
Lager et al., "Histologic findings of antibody-mediated rejection in ABO blood-groupincompatible living-donor kidney transplantation," American Journal of Transplantation, vol.
In several studies, C1q-positive DSA had associated with antibody-mediated rejection in renal transplantation compared with antibodies identified only by IgG [71, 107].
Initial pancreas transplant was 12 years prior, complicated by antibody-mediated rejection. Patient received her second pancreas from a deceased male donor.
In recent years, organ transplant pathology has evolved with recognition of antibody-mediated rejection (ABMR) in kidney and subsequently in almost all transplanted solid organ systems.
Clinical charts were reviewed to assess demography and study outcomes that comprised overall survival, early graft failure, early and late cellular rejection, and pathological antibody-mediated rejection (AMR) [8].
A: Antibody-mediated rejection (AMR) in ABO-incompatible (ABOi) or human leukocyte antigen (HLA)-sensitized kidney transplant recipients has been known to result in a high incidence of graft failure despite immunosuppressive drug therapy (Padmanabhan, Jhang, Rather, & Schwartz, 2007).

Full browser ?